...
首页> 外文期刊>Growth hormone and IGF research: Official journal of the Growth Hormone Research Society and the International IGF Research Society >Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes.
【24h】

Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes.

机译:妊娠引起的循环IGF-1升高与1型糖尿病女性糖尿病性视网膜病变的进展有关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To evaluate the influence of Insulin-like Growth factor-I (IGF-I) and Placental Growth Hormone (GH) on progression of diabetic retinopathy during pregnancy in women with type 1 diabetes. DESIGN: Observational study of 88 consecutive pregnant women with type 1 diabetes for median 16.5 years (range 1-36) and HbA(1c) 6.6% (5.2-10.5) in early pregnancy. At 8, 14, 21, 27 and 33 weeks blood samples were drawn for measurement of IGF-I, placental GH and Hemoglobin A(1c) (HbA(1c)) and blood pressure was recorded. Fundus photography was performed at 8 and 27 weeks. Diabetic retinopathy was classified in five stages. Progression was defined as deterioration of at least one stage of diabetic retinopathy and/or development of macular edema on at least one eye. RESULTS: Placental GH and IGF-I levels increased throughout pregnancy and new onset or progression of diabetic retinopathy occurred in 22 (25%). A steeper increase in women with progression of diabetic retinopathy resulted in higher IGF-I levels at 27 weeks (p=0.01) and 16% higher IGF-I levels throughout pregnancy (p=0.02) compared with women without progression while similar levels of placental GH (p=0.58) and HbA(1c) (p=0.85) were observed throughout pregnancy. In a multivariate logistic regression analysis, progression of diabetic retinopathy was associated with higher IGF-I levels at 33 weeks (odds ratio 2.0 [95% confidence interval 1.1-3.6], p=0.02) and higher systolic blood pressure at 8 weeks (1.9 [1.1-3.2], p=0.02) independent of placental GH and HbA(1c) levels. CONCLUSIONS: Pregnancy-induced increase in IGF-I levels is associated with progression of diabetic retinopathy in women with type 1 diabetes.
机译:目的:评估胰岛素样生长因子-I(IGF-I)和胎盘生长激素(GH)对1型糖尿病妇女妊娠期糖尿病性视网膜病变进展的影响。设计:对88名连续1型糖尿病孕妇进行了观察性研究,她们中位数16.5岁(范围1-36),早期妊娠HbA(1c)6.6%(5.2-10.5)。在第8、14、21、27和33周时抽取血液样本以测量IGF-I,胎盘GH和血红蛋白A(1c)(HbA(1c)),并记录血压。在第8和27周进行眼底照相。糖尿病性视网膜病分为五个阶段。进展被定义为糖尿病性视网膜病的至少一个阶段的恶化和/或至少一只眼睛上的黄斑水肿的发展。结果:在整个妊娠过程中胎盘GH和IGF-I水平升高,有22位(25%)发生新发糖尿病或视网膜病变。与没有进展且胎盘水平相似的妇女相比,患有糖尿病性视网膜病变的妇女的急剧增加导致27周时的IGF-I水平升高(p = 0.01),整个妊娠期间的IGF-I水平升高16%(p = 0.02)。整个怀孕期间观察到GH(p = 0.58)和HbA(1c)(p = 0.85)。在多因素logistic回归分析中,糖尿病性视网膜病变的进展与33周时IGF-I水平升高(赔率比2.0 [95%置信区间1.1-3.6],p = 0.02)和8周时收缩压升高(1.9)有关。 [1.1-3.2],p = 0.02)与胎盘GH和HbA(1c)水平无关。结论:妊娠诱导的IGF-I水平升高与1型糖尿病女性糖尿病性视网膜病变的进展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号